Finch Therapeutics Group Inc

OTCPK:FNCH (USA)  
$ 10.80 0 (0%) 11:08 PM EST
At Loss
P/B:
1.22
Market Cap:
$ 17.34M
Enterprise V:
$ 30.30M
Volume:
2.02K
Avg Vol (2M):
3.49K
Trade In:
Volume:
2.02K
At Loss
Avg Vol (2M):
3.49K

Business Description

Finch Therapeutics Group Inc
NAICS : 325412 SIC : 2834
ISIN : US31773D2009
Description
Finch Therapeutics Group Inc is a microbiome technology company with a portfolio of intellectual property and microbiome assets. Finch has a robust intellectual property estate reflecting the company's pioneering role in the microbiome therapeutics field, including more than 70 issued U.S. and foreign patents with critical relevance for both donor-derived and donor-independent microbiome therapeutics in a range of potential indications. The company's assets include CP101, an investigational, orally administered microbiome candidate with positive clinical date from a Phase 2 randomized, placebo-controlled trial and a Phase 2 open-label trial in recurrent C. difficile infection (CDI).
Name Current Vs Industry Vs History
Cash-To-Debt 0.55
Equity-to-Asset 0.31
Debt-to-Equity 2.04
Debt-to-EBITDA -1.49
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.12
9-Day RSI 38.31
14-Day RSI 40.64
6-1 Month Momentum % 871.77
12-1 Month Momentum % 238.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.87
Quick Ratio 3.87
Cash Ratio 3.59

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.6
Shareholder Yield % 75.56

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin % -16873.83
ROE % -64.48
ROA % -25.54
ROIC % -62.4
ROC (Joel Greenblatt) % -72.94
ROCE % -39.24

Financials (Next Earnings Date:2025-03-24 Est.)

FNCH's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:FNCH

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Finch Therapeutics Group Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.107
EPS (TTM) ($) -8.82
Beta 1.5
Volatility % 677.2
14-Day RSI 40.64
14-Day ATR ($) 0.39103
20-Day SMA ($) 11.52805
12-1 Month Momentum % 238.48
52-Week Range ($) 0.8 - 14.26
Shares Outstanding (Mil) 1.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Finch Therapeutics Group Inc Filings

Filing Date Document Date Form
No Filing Data

Finch Therapeutics Group Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Finch Therapeutics Group Inc Frequently Asked Questions

What is Finch Therapeutics Group Inc(FNCH)'s stock price today?
The current price of FNCH is $10.80. The 52 week high of FNCH is $14.26 and 52 week low is $0.80.
When is next earnings date of Finch Therapeutics Group Inc(FNCH)?
The next earnings date of Finch Therapeutics Group Inc(FNCH) is 2025-03-24 Est..
Does Finch Therapeutics Group Inc(FNCH) pay dividends? If so, how much?
Finch Therapeutics Group Inc(FNCH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1